BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 114895
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.114895
Which lymph node dissection should be performed in advanced distal gastric cancer? A critical assessment of D2 lymphadenectomy
Giuseppe Brisinda, Maria Michela Chiarello, Filomena Misuriello, Maria Cariati, Giuseppe Tropeano, Edoardo Piras, Gaia Altieri, Giada Bracalente, Valerio Papa
Giuseppe Brisinda, Gaia Altieri, Emergency Surgery and Trauma Center, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome 00168, Italy
Giuseppe Brisinda, Filomena Misuriello, Edoardo Piras, Giada Bracalente, Department of Medicine and Surgery, Catholic School of Medicine, Rome 00168, Italy
Maria Michela Chiarello, Department of Surgery, Provincial Health Authority, Cosenza 87100, Italy
Maria Cariati, Department of Surgery, Provincial Health Authority, Crotone 88900, Italy
Giuseppe Tropeano, Department of General Surgery, Delta Hospital, Chirec Group, Brussels 1160, Brussels-Capital Region, Belgium
Valerio Papa, Department of Medical and Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, St. Andrea Hospital, “La Sapienza” University, Rome 00189, Italy
Author contributions: Brisinda G, Chiarello MM, and Papa V conceived the original idea; Misuriello F, Cariati M, Tropeano G, Piras E, Altieri G, and Bracalente G performed a comprehensive review of all available literature and synthesized the data. All authors wrote the manuscript, performed a critical appraisal of the manuscript, and read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Giuseppe Brisinda, MD, Professor, Emergency Surgery and Trauma Center, Fondazione Policlinico Universitario A Gemelli IRCCS, No. 8 Largo Agostino Gemelli, Rome 00168, Italy. gbrisin@tin.it
Received: October 9, 2025
Revised: December 28, 2025
Accepted: January 21, 2026
Published online: March 27, 2026
Processing time: 178 Days and 3.8 Hours
Abstract

Lymph node invasion stands out as the most critical prognostic factor in gastric cancer. The extent of lymph node dissection required during curative gastric cancer surgery has long been debated. Japanese Gastric Cancer Association was the first to define a classification system for regional gastric lymph node stations, numbering them from No. 1 to No. 16. This classification was later used to differentiate between different types of lymph node dissection, such as D1, D2 and D3. However, these definitions were often considered too complex to be universally adopted, resulting in wide variations of recommendations from one country to another and making it difficult to compare published studies. Moreover, the optimal extent of lymph node dissection remains uncertain, as the extensive dissections that where initially recommended are associated with significant morbidity without a clear survival benefit. Though gastrectomy with extended D2 lymphadenectomy is classified as a non-standard gastrectomy, its clinical significance has been evaluated in many studies. D2 plus superior mesenteric vein lymph node (No. 14v) dissection is recommended when metastasis to No. 6 nodes is suspected in the lower stomach, and D2 plus posterior surface of the pancreatic head (No. 13) lymph node dissection may be an option in potentially curative gastrectomy for cancer invading the duodenum. No. 14v lymph node dissection has been shown to improve overall survival in patients with distal gastric cancer, primarily in patients with clinical stage III/IV distal gastric cancer. Furthermore, D2 plus lymphadenectomy showed a significantly higher 5-year overall survival rate (55.3% vs 43.9%) and a lower recurrence rate (51.5% vs 69.5%) then D2 standard dissection. The quality of lymphadenectomy may influence prognosis in gastric cancer patients. Both hospital volume and surgeon volume were important factors for the quality of radical gastrectomy. The purpose of this review is to support the extension of lymph node dissection based on the existing literature, including a comprehensive review of current definitions of lymphadenectomy. An outcome analysis is performed to assess the need for lymphadenectomy with removal of lymph nodes not included in the standard D2 lymphadenectomy in patients with distal gastric cancer, especially if the tumor is advanced.

Keywords: Gastric cancer; Lymph node dissection; Lymph nodes metastases; Guidelines; Surgery

Core Tip: The extent of lymphadenectomy influences the prognosis in patients with distal gastric cancer. The most authoritative guidelines recommend a D2 lymphadenectomy in T2-T4 tumors, as well as T1N+, regardless of tumor location. The purpose of this review is to support the extension of lymph node dissection based on the existing literature. An analysis of the results is performed to assess the need for lymphadenectomy with removal of lymph nodes not included in the standard D2 lymphadenectomy in patients with distal gastric cancer, especially if the tumor is advanced.